Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
antisense, ASO, cell, compliance, comply, Cosmetic, escrow, external, FDCA, force, hearing, higher, IND, jointly, lack, nondiscretionary, nucleic, oligonucleotide, opportunity, peptide, preliminarily, proprietary, publish, published, rare, Register, sNDA, successful, timeframe
Removed:
Department, DOJ, enrolling, Justice, LQTM
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view